No Data
No Data
Guggenheim Cuts Biogen Price Target to $168 From $190
A Quick Look at Today's Ratings for Biogen(BIIB.US), With a Forecast Between $135 to $260
RBC Capital has lowered the Target Price for BeiGene to $225.
RBC Capital has lowered Biogen's Target Price from $231 to $225, maintaining an "outperform Large Cap" rating. (Gelonghui)
Biogen (BIIB) Receives a Buy From Evercore ISI
Biogen's Growth Potential Amidst Challenges: A Buy Rating by Marc Goodman
Biogen's Earnings Call Highlights: New Product Success Amid MS Declines
72886030 : any thoughts why it is dropping after the earnings?
thoughtful Bat_8163 OP 72886030 : forecast? To be honest, it is really disappointing regarding Leqembi rollout. BIIB has betted huge on it. I was expecting much better quarter over quarter growth
72886030 thoughtful Bat_8163 OP : thanks for sharing. hope all the bad news are priced in now.